Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases.
第一作者:
Timo,Rath
第一单位:
Department of Medicine 1, Division of Gastroenterology, Pneumology and Endocrinology, Ludwig Demling Endoscopy Center of Excellence, University of Erlangen-Nuremberg, Erlangen, Germany.
作者:
医学主题词
成年人(Adult);细胞, 培养的(Cells, Cultured);细胞因子类(Cytokines);女(雌)性(Female);胃肠病用药(Gastrointestinal Agents);人类(Humans);炎性肠疾病(Inflammatory Bowel Diseases);整合素类(Integrins);男(雄)性(Male);中年人(Middle Aged);缓解诱导(Remission Induction);信号传导(Signal Transduction);青年人(Young Adult)
DOI
10.3389/fimmu.2018.01700
PMID
30131801
发布时间
2019-09-09
- 浏览4
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



